Month: May 2025

Foremost Clean Energy Successfully Regains Compliance with Nasdaq Minimum Bid Price Requirement Supported by Significant Trading Volume and +260% Increase in Share Price

Written by Customer Service on May 27, 2025. Posted in Public Companies.

Share price increased by 264% from April 7, 2025 (non-compliance notice) to US$2.60 by May 22, 2025 (compliance achieved) indicating strong market sentiment and investor confidence in Foremost’s business strategy VANCOUVER, British Columbia, May 27, 2025 (GLOBE NEWSWIRE) — Foremost Clean Energy Ltd. (NASDAQ: FMST) (CSE: FAT) (“Foremost” or the “Company”) an emerging North American uranium and lithium exploration company, today announced that on May 23, 2025, it received written notice (the “Compliance Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) informing the Company that it had regained compliance with Nasdaq Listing Rule 5550(a)(2) (the “Nasdaq Listing Rule”), which requires that companies listed on Nasdaq maintain a minimum bid price of US$1.00 per share. The Company was previously notified by Nasdaq that it was not...

SAGA Metals Announces First Tranche Closing

Written by Customer Service on May 27, 2025. Posted in Public Companies.

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. VANCOUVER, British Columbia, May 27, 2025 (GLOBE NEWSWIRE) — SAGA Metals Corp. (the “Company” or “SAGA”) (TSXV: SAGA) (OTCQB: SAGMF) (FSE: 20H), a North American exploration company focused on critical mineral discovery in Canada, is pleased to announce that it has closed a first tranche (the “First Tranche”) of its non-brokered private placement announced on May 2, 2025 (the “Offering”) for gross proceeds of $1,239,700.10. The Company has also received a 30-day extension to close the Offering from the TSX Venture Exchange, and accordingly expects to close the final tranche of the Offering on or before June 25, 2025. On closing of the First Tranche, the Company received gross proceeds of $444,200.10 from the issuance of 1,480,667 flow-through...

Moomoo Expands into Cryptocurrency Market with Launch of New Digital Asset Business

Written by Customer Service on May 27, 2025. Posted in Public Companies.

JERSEY CITY, N.J., May 27, 2025 (GLOBE NEWSWIRE) — Moomoo, a global investment and trading platform, is thrilled to announce its expansion into cryptocurrency trading with the upcoming launch of Moomoo Crypto, a comprehensive digital asset investment service for its U.S. users. The new U.S. Crypto’s plan to launch over 30 coins is an exciting option for moomoo investors to trade on its all-in-one trading platform. Moomoo leverages its established technology infrastructure and user-friendly interface to provide a seamless trading experience across both traditional securities through Moomoo Financial and digital assets through Moomoo Crypto. It will initially support trading of major cryptocurrencies including Bitcoin, Ethereum, and several other leading tokens for its current users, with plans to expand its offerings in the...

Mangoceuticals’ Patented MGX-0024 Delivers 100% Respiratory Survival in Poultry Studies Signaling Strong Potential Defense Against Spread of Avian Flu

Written by Customer Service on May 27, 2025. Posted in Public Companies.

Dallas, TX, May 27, 2025 (GLOBE NEWSWIRE) — Mangoceuticals, Inc. (NASDAQ: MGRX) (“Mangoceuticals” or the “Company”), a company focused on developing, marketing, and selling a variety of health and wellness products via a secure telemedicine platform under the brands MangoRx and PeachesRx, and a pioneer in innovative wellness solutions, is excited to share groundbreaking results from field studies based on its patented antiviral compound which it refers to as “MGX-0024”. The field studies were conducted by Solice International at Duraiswamy Farm in Palladam, Tamil Nadu, India. These studies, targeting respiratory diseases in chickens, like Newcastle Disease and Chronic Respiratory Disease (CRD), showed MGX-0024, delivered through drinking water, achieved 100% survival against respiratory illnesses in a large-scale...

High Roller Submits Gaming License Application in Ontario, Targets H2 2025 Launch

Written by Customer Service on May 27, 2025. Posted in Public Companies.

Las Vegas, Nevada, May 27, 2025 (GLOBE NEWSWIRE) — High Roller Technologies (“High Roller” and the “Company”) (NYSE: ROLR), operator of the premium online casino brands High Roller and Fruta, today announced the submission of its Internet Gaming Operator license application in Ontario, Canada, targeting the launch of its flagship brand HighRoller.com in the second half of 2025. “The submission of our licensing application to access Ontario’s regulated online gambling market is an important milestone in our Company’s journey,” commented Ben Clemes, Chief Executive Officer at High Roller. “Once our application is approved, we anticipate that we will have the opportunity to launch our online casino product into the market later this year.” Ontario is one of the largest regulated online gambling markets in the world as measured by...

Antalpha Announces Strategic Investment in Tether Gold and Expansion into New Lending Verticals

Written by Customer Service on May 27, 2025. Posted in Public Companies.

SINGAPORE, May 27, 2025 (GLOBE NEWSWIRE) — Antalpha Platform Holding Company (NASDAQ: ANTA) (“Antalpha” or the “Company”), a leading fintech platform serving the Bitcoin mining ecosystem, today announced strategic initiatives to strengthen its treasury plan and expand its product offering. Strategic Allocation into Tether Gold (XAUt)Antalpha intends to allocate up to US $40 million equivalent in XAUt at market price from now until June 30, 2026. The Company views this allocation as a strategic hedge against macroeconomic volatility, a tool to diversify its institutional collateral base, and a means to offer its clients access to stable-value lending solutions to hedge against periods of market uncertainty. The Company believes that XAUt offers strong strategic value for institutional asset allocation, particularly in its potential...

NurExone Biologic Inc. Announces First Quarter 2025 Financial Results and Provides Corporate Update

Written by Customer Service on May 27, 2025. Posted in Earnings Releases And Operating Results.

TORONTO and HAIFA, Israel, May 27, 2025 (GLOBE NEWSWIRE) — NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“ NurExone ” or the “ Company ”), a preclinical-stage biotechnology company pioneering exosome-based therapies for central nervous system injuries, is pleased to announce its financial results for the first quarter ended March 31, 2025, and provides a corporate update on its recent activities and upcoming milestones. The Company’s full set of unaudited condensed interim consolidated financial statements for the three months ended March 31, 2025, and accompanying management’s discussion and analysis can be accessed by visiting the Company’s website at www.nurexone.com and its SEDAR+ profile at www.sedarplus.ca. Key Business HighlightsInclusion in the 2025 TSX Venture 50™ list of top-performing...

TRESU Investment Holding A/S – Announcement of Q1 2025 Interim Report

Written by Customer Service on May 27, 2025. Posted in Earnings Releases And Operating Results.

TRESU INVESTMENT HOLDING A/S ANNOUNCEMENT NO. 07.2025 27.05.2025 TRESU Investment Holding A/S – Announcement of Q1 2025 Interim Report Tresu Investment Holding A/S today publishes the Q1 2025 Interim Report and presentation of the financial results. We are pleased to invite you to the financial results call, which is being held Wednesday, 11. June 2025, at 1pm CET. The Interim Report will be presented by Stephan Plenz, CEO and Torben Børsting, CFO. After the presentations there will be an opportunity for Q+A. A recording of the results call will be made available for four hours on the TRESU IR website. To register for the investor call, please send an e-mail to fho@tresu.com directed to Financial Manager at TRESU A/S, Finn Holm, no later than 10. June 2025 9am CET. Stephan plenz CEO, TRESU For...

Teva and Biolojic Design Initiate IND-enabling Studies of BD9, a Multibody Designed to Explore the Treatment of Atopic Dermatitis and Asthma

Written by Customer Service on May 27, 2025. Posted in Public Companies.

BD9 is a multibody that targets IL-13 and TSLP, and has potential to treat TH-2-driven inflammatory diseasesBD9 designed using Biolojic’s Multibody Platform, which generates Antibodies capable of addressing multiple disease targetsCollaboration builds on Teva’s Pivot to Growth strategy to step up innovation in Teva’s innovative pipelineREHOVOT, Israel and WASHINGTON and TEL AVIV, Israel, May 27, 2025 (GLOBE NEWSWIRE) — Teva Pharmaceutical Industries Ltd., (NYSE and TASE:TEVA) and Biolojic Design Ltd. (“Biolojic”), a biotechnology company using computational biology and artificial intelligence to design next generation, multifunctional antibodies known as multibodies, announced today that Teva initiated IND-enabling studies with BD9, a dual-specific multibody targeting both TSLP (Thymic stromal lymphopoietin) and IL-13....

GCM Grosvenor to Present at the Morgan Stanley 2025 U.S. Financials, Payments & CRE Conference on June 10, 2025

Written by Customer Service on May 27, 2025. Posted in Public Companies.

CHICAGO, May 27, 2025 (GLOBE NEWSWIRE) — GCM Grosvenor (Nasdaq: GCMG), a global alternative asset management solutions provider, announced today that Jon Levin, President of GCM Grosvenor, will present at the Morgan Stanley 2025 U.S. Financials, Payments & Commercial Real Estate Conference on Tuesday, June 10, 2025, at 3:15 PM EDT. A link to the live audio webcast of the presentation will be available on GCM Grosvenor’s public shareholders website and the event website. For those unable to listen to the live audio webcast, a replay will be available for 90 days following the presentation. About GCM Grosvenor GCM Grosvenor (Nasdaq: GCMG) is a global alternative asset management solutions provider with approximately $82 billion in assets under management across private equity, infrastructure, real estate, credit, and absolute...

Month: May 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals